|
|
| MRD / Regn No. |
: 20240000137 |
Date |
: 21/07/2026 |
| Patient Name |
: Abdul Rashid Naskar |
Age & Gender |
: 72 Yrs. / Male |
| Contact No. |
: 7003312201 |
UHID |
: |
| Ht / Wt / BMI |
: 161 / 56.8 / 21.91 |
BP S / BP D |
: 140 / 75 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (21/Feb/2023) | |
|
Subjective |
: |
DIAGNOSED DM 1 YEAR
|
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM,INCREASED FIB4 / NAFLD SCORE,THROMBOCYTOPENIA,S3F0 MASLD |
|
Plan |
: |
CHANGE TO DPP4I SGLT2I,SEE ME IN 2 MONTHS WITH TESTING |
|
| Salient Investigations |
: |
BUN BLOOD UREA NITROGEN: 22 mg/dL | CREATININE: 1.1 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 70.11 mL/min/1.73m2 | URIC ACID: 5.8 | BICARBONATE: 28 meq/L | CHLORIDE: 104 meq/L | POTASSIUM: 3.8 meQ/L | SODIUM: 143 meq/L | HDL HIGH DENSITY LIPOPROTEIN: 41 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 83 mg/dL | TGL TRIGLYCERIDE: 71 mg/dL | TOTAL CHOLESTEROL: 140 mg/dl | ALKALINE PHOSPHOTASE: 91 IU/L | DIRECT BILIRUBIN: 0.2 mg/dl | SGOT (AST): 21 U/L | SGPT (ALT): 19 IU/L | TOTAL BILIRUBIN: 0.4 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.6 % | TSH : 2.6 mIU/L | VITAMIN D (25 OH): 38.8 ng/mL | HEMOGLOBIN: 13.3 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 85.6 fL | WBC WHITE BLOOD CELLS: 591 K/uL |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
EMPAGLIFLOZIN 10 MG LINAGLIPTIN 5 MG
GLYXAMBI 10/5 |
|
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| EMPAGLIFLOZIN MAY CAUSE GENITOURINARY INFECTION KEEP GENITAL AREA CLEAN | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 20/Aug/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP BUN CR URINE MICROALBUMIN |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
This is a Computer generated Prescription |
Powered By:  |